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ABSTRACT: The aim of the present study was to evaluate the association between history of
tuberculosis and airflow obstruction.
A population-based, multicentre study was carried out and included 5,571 subjects aged
o40 yrs living in one of five Latin American metropolitan areas: Sao Paulo (Brazil); Montevideo
(Uruguay); Mexico City (Mexico); Santiago (Chile); and Caracas (Venezuela). Subjects performed
pre- and post-bronchodilator spirometry and were asked whether they had ever been diagnosed
with tuberculosis by a physician.
The overall prevalence of airflow obstruction (forced expiratory volume in one second/forced
vital capacity post-bronchodilator ,0.7) was 30.7% among those with a history of tuberculosis,
compared with 13.9% among those without a history. Males with a medical history of tuberculosis
were 4.1 times more likely to present airflow obstruction than those without such a diagnosis. This
remained unchanged after adjustment for confounding by age, sex, schooling, ethnicity, smoking,
exposure to dust and smoke, respiratory morbidity in childhood and current morbidity. Among
females, the unadjusted and adjusted odds ratios were 2.3 and 1.7, respectively.
In conclusion, history of tuberculosis is associated with airflow obstruction in Latin American
middle-aged and older adults.
KEYWORDS: Chronic bronchitis, chronic obstructive pulmonary disease, developing countries,
smoking, spirometry, tuberculosis
A
ccording to the global burden of disease
projections [1], chronic obstructive pul-
monary disease (COPD) and tuberculosis
(TB) are among the 10 leading causes of death
and disability for low- and middle-income
countries at the beginning of the 21st century
(sixth and eight, respectively). This scenario
differs from that observed in high-income coun-
tries, where TB is not among the top 10 causes [1].
Brazil, the largest country in Latin America, is
one of 22 countries in the world that accounts for
80% of the TB cases according to the World Heath
Organization [2]. Poverty, malnutrition, high
rates of HIV infection, smoking and the huge
socioeconomic disparities observed in low- and
middle-income countries contribute to the high
prevalence of TB [2].
Previous studies have suggested that pulmonary
TB is associated with airflow obstruction. Most
were carried out in Africa [3–6] and Asia [7–9].
The Latin American literature on this issue is
scarce; the current authors found only two
papers, one from Chile and one from Brazil,
published in the last 10 yrs [10, 11]. Most studies
had small samples and only one was population
based. Post-bronchodilator spirometry, the gold
standard for measuring airway obstruction, was
used in several studies, but not in the population-
based survey [4].
The Latin American Project for the Investigation
of Obstructive Lung Disease (PLATINO study)
[12], a multicentre, population-based project
conducted in five sites of Latin America, allowed
the present authors to investigate the association
between airflow obstruction (measured by spiro-
metry) and TB (evaluated by medical diagnosis).
The aim of the current study was to evaluate the
association between airflow obstruction and TB.
METHODS
The PLATINO study was launched in 2002 [12].
The project focused on COPD and related
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variables, including five major cities in Latin America: Sao
Paulo (Brazil); Santiago (Chile); Mexico City (Mexico);
Montevideo (Uruguay); and Caracas (Venezuela). The detailed
methodology of the multicentre study was published else-
where [13]. In brief, multistage sampling strategies were used
to select subjects aged o40 yrs in the five metropolitan areas,
after stratification by administrative regions (main city and
suburbs) and socioeconomic status of census tracts. An average
of 15 households in 68 census tracts was visited per site. The
sample was self-weighted in each city.
Interviews and examinations took place at the subjects’ homes.
Subjects performed pre- and post-bronchodilator (BD) spiro-
metry using a portable, battery-operated, ultrasound transit-
time based spirometer (Easy-One2; NDD Medical
Technologies, Chelmsford MA, USA and Zurich,
Swizerland). Approximately 90% of all tests achieved ‘‘grade
A’’ and almost 95% fulfilled the American Thoracic Society
(ATS) criteria of quality. Exclusion criteria for spirometry
followed the ATS recommendations. Spirometric results were
first presented as continuous variables: pre- and post-BD;
forced expiratory volume in one second (FEV1); forced vital
capacity (FVC); and FEV1/FVC. Two categorical variables
were also created: airflow obstruction (yes or no) using a cut-
off point of 0.7 in the post-BD FEV1/FVC ratio [14]; and the
Global Initiative for Chronic Obstructive Lung Disease (GOLD)
stages, using predicted values for normal lung function
derived from the data from the present study [15]. GOLD
categories II–IV were combined due to the small number of
subjects in stages III and IV.
Information on medical diagnosis of TB was based on the
question: ‘‘Has a doctor or other healthcare provider ever told
you that you had tuberculosis?’’ For those who answered yes,
the authors asked whether or not the subject used medication
to treat the disease. Confounding variables included sex, age,
ethnicity, schooling, smoking status, smoking history (pack-
yrs), hospital admissions due to pulmonary problems in
childhood, exposure to domestic biomass and coal pollution,
occupational exposure to dust, body mass index and comorbid-
ity (medical diagnosis of heart problems, hypertension, diabetes
and stroke).
The combined sample size (,5,600 individuals) allowed the
current authors to detect significant odds ratios (ORs) of o1.8
for the association between airflow obstruction (prevalence of
,15%) and medical diagnosis of TB (prevalence of ,2.5%)
with power of 80% and confidence level of 95%.
All analyses were stratified by study site. The analyses
included a description of the sample, calculation of the
prevalence of TB according to categories of the confounding
variables, evaluation of mean spirometric results for subjects
with and without a medical diagnosis of TB, and logistic
regression using the history of TB as the main exposure of
interest. In the unadjusted analyses, Wald tests for hetero-
geneity or linear trend were applied, except when continuous
variables were analysed; in this case, one-way ANOVA was
used. Three logistic regression models for the association
between medical diagnosis of TB and airflow obstruction were
used. In the first, the crude association between the variables
was studied. Secondly, the association was adjusted for
sociodemographic variables, smoking, indoor and occupa-
tional exposure to pollution, and history of hospitalisation. In
the last model, comorbidity indicators were also included. All
analyses were repeated for males and females separately.
The study was approved by the Ethical Review Boards of the
five institutions from the participating countries. Written
informed consent was obtained from all participants, and
confidentiality was ensured.
RESULTS
Detailed data on the sample included in the PLATINO study
are available in previous publications [16]. In brief, 1,000
individuals aged o40 yrs were interviewed in Sao Paulo, 1,208
in Santiago, 1,063 in Mexico City, 943 in Montevideo and 1,357
in Caracas. Nonresponse rates, including the spirometric
evaluation, ranged from 31.1% in Mexico City to 16.3% in
Sao Paulo. Nonrespondents were very similar to respondents
in terms of cigarette smoking and age; the nonresponse rate
was higher in males than females [16].
Out of 5,571 subjects, 132 (2.4%) reported a medical diagnosis
of TB. Of these, 105 reported the utilisation of medication to
treat the disease. Table 1 describes the sample in terms of
sociodemographic, behavioural, indoor and occupational
exposure, and past and current morbidity. The male/female
ratio was 0.65, mean¡SD age was 56.6¡11.9 yrs, the median
duration of schooling was 6 yrs and more than half of the
subjects (3,012 out of 5,553) reported their skin colour as white.
Prevalence of current smoking was 29.2% (1,625 out of 5,569)
and 30.0% (1,660 out of 5,536) of all subjects were obese (body
mass index o30 kg?m-2). History of hospitalisation due to
respiratory problems in childhood was present for 2.2% (121
out of 5,569) of the subjects. Exposure to coal for cooking or
heating was reported by 22.8% (1,269 out of 5,563) of the
subjects, while exposure to biomass was positive for 44.4%
(2,467 out of 5,559). Half of the subjects (2,840 out of 5,564) had
never been exposed to dust at the workplace, while 27.8%
(1,548 out of 5,564) were exposed for o10 yrs. In terms of
comorbidity, 34.9% (1,943 out of 5,570) of the subjects reported
suffering from hypertension, 13.6% (755 out of 5,570) from
heart problems, 10% (554 out of 5,569) from diabetes and 2.4%
(133 out of 5,568) had a history of stroke.
Table 1 also presents the prevalence of medical diagnosis of TB
according to the independent variables included in the survey.
A positive association was detected between TB and age. TB
was reported more often by subjects who were admitted to
hospitals in childhood due to respiratory problems, those who
were exposed to dust at the workplace, and those who were
exposed to coal or biomass for cooking or heating. In terms of
comorbidity, subjects with medical diagnoses of hypertension
or stroke were more likely to report a medical diagnosis of TB.
In table 2, spirometric results are compared among subjects
with and without a medical diagnosis of TB. For all spirometric
indices, those with TB performed less well, although the
relative difference tended to be greater for FEV1 than for FVC.
When the spirometric values were converted into categorical
outcomes, the association between TB and airflow obstruction
was still significant and strong. Figure 1 shows the prevalence
of medical diagnosis of TB according to the COPD stages of
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TABLE 1 Prevalence of medical diagnosis of tuberculosis
Variable Sample n Medical diagnosis of tuberculosis
% p-value#
Sex 0.11
Male 2192 2.0
Female 3379 2.6
Age yrs 0.000
40–49 1988 1.5
50–59 1625 2.3
o60 1894 3.4
Highest degree of schooling 0.68
0–2 733 2.2
3–4 858 2.9
5–8 1882 2.2
o9 2090 2.4
Ethnic origin 0.23
White 3012 2.4
Mixed 1889 2.1
Black 323 2.8
Indigenous 277 4.3
Asian 52 1.9
Smoking status 0.56
Never-smoker 2400 2.2
Former smoker 1544 2.7
Current smoker 1625 2.3
Smoking exposure pack-yrs 0.87
0–9.9 3801 2.3
10–19.9 712 2.5
o20 1030 2.5
Body mass index kg?m-2 0.15
,25 1597 2.9
25–29.9 2279 2.0
o30 1660 2.4
Hospital admission due to pulmonary problems in childhood 0.000
No 5448 2.1
Yes 121 13.2
Indoor exposure to coal for cooking or heating 0.000
No 4294 1.8
Yes 1269 4.3
Indoor exposure to biomass for cooking or heating 0.000
No 3092 1.7
Yes 2467 3.3
Exposure to dust at the workplace 0.03
Never 2840 1.9
,10 1176 2.6
o10 1548 3.0
Medical diagnosis of hypertension 0.001
No 3627 1.9
Yes 1943 3.3
Medical diagnosis of diabetes 0.97
No 5015 2.4
Yes 554 2.4
Medical diagnosis of heart problems 0.57
No 4815 2.3
Yes 755 2.7
#: Wald test for heterogeneity (dichotomous exposures and ethnicity) or linear trend (ordinal exposures).
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severity proposed by the GOLD classification. A history of TB
was clearly associated with more severe grades of obstruction.
Table 3 presents the ORs for airflow obstruction (FEV1/FVC
,0.70) according to reported TB. In the unadjusted analysis,
the OR for obstruction was 4.06. Adjustment for different
combinations of confounding variables did not change the
crude results for males, with the adjusted OR being 3.99. For
females, the magnitude of the association was lower than for
males in the unadjusted analysis (OR 2.34); it was further
reduced to 1.71 in the fully adjusted model (p50.08). For both
sexes combined, those with TB presented an OR of 2.33
compared with those without TB in the fully adjusted model.
Slightly stronger associations are obtained if airflow obstruc-
tion is defined as an FEV1/FVC lower than the fifth percentile
for age, height and sex [15], that differ from the GOLD criteria,
taking into account the decrease in FEV1/FVC with ageing
(data available upon request).
DISCUSSION
In a population-based, multicentre study covering five large
metropolitan areas in Latin America, a strong association was
shown between a medical history of TB and airflow obstruc-
tion among subjects aged o40 yrs. To the current authors’
knowledge, this is the first population-based study exploring
this association using post-BD spirometry. Previous studies on
the subject included occupational cohorts with high prevalence
of lung disease or addressed the natural history of TB,
including its effect on airflow obstruction, without an internal
comparison group. It is well known that history of TB may
affect lung function, either by pleural changes, bronchial
stenosis or parenchymal scarring. Extensive lesions may
produce restrictive changes with reduced transfer factor of
the lung for carbon monoxide, but obstructive alterations were
also identified many years ago [17, 18].
The association of TB with FEV1 values (mean difference
0.35 mL) was stronger than for FVC (0.25 mL) and, as a result,
the FEV1/FVC ratio showed a marked reduction, characterised
by an obstructive pattern. Earlier studies that did not rely on
post-BD spirometry suggested that TB can lead to chronic
airflow obstruction [19–21], but subjects diagnosed with
obstruction may be asthmatic, which is markedly less likely
when a BD is used [14].
The current definition of COPD according to the GOLD criteria
[14] takes into account history of smoking; therefore, the current
authors opted to use the terminology ‘‘airflow obstruction’’
instead of COPD throughout the study. The present findings
suggest that the limitation to airflow caused by TB is
TABLE 2 Spirometry results according to medical
diagnosis of tuberculosis
Spirometric values Medical diagnosis of
tuberculosis
p-value#
No Yes
FEV1 pre-BD 2.54¡0.77 2.17¡0.71 0.000
FEV1 pre-BD % pred " 95.69¡18.32 88.14¡22.27 0.000
FEV1 post-BD 2.63¡0.77 2.26¡0.70 0.000
FEV1 post-BD % pred 95.82¡17.14 91.43¡18.80 0.007
FVC pre-BD 3.37¡0.97 3.15¡0.93 0.009
FVC pre-BD % pred 98.69¡16.96 98.15¡20.18 0.72
FVC post-BD 3.38¡0.94 3.12¡0.88 0.003
FVC post-BD % pred 98.12¡15.52 96.13¡16.34 0.16
FEV1/FVC pre-BD 0.75¡0.09 0.69¡0.11 0.000
FEV1/FVC pre-BD % pred 97.72¡10.76 90.21¡13.11 0.000
FEV1/FVC post-BD 0.78¡0.08 0.73¡0.11 0.000
FEV1/FVC post-BD % pred 97.85¡10.00 91.79¡13.27 0.000
Data are presented as mean¡SD. FEV1: forced expiratory volume in one
second; BD: bronchodilator; % pred: % predicted; FVC: forced vital capacity.
#: one way ANOVA; ": predicted values were based on the PLATINO reference
curves.
Variable Sample n Medical diagnosis of tuberculosis
% p-value#
Medical diagnosis of stroke 0.000
No 5435 2.2
Yes 133 7.5
#: Wald test for heterogeneity (dichotomous exposures and ethnicity) or linear trend (ordinal exposures).
TABLE 1 Continued.
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FIGURE 1. Prevalence of different stages of chronic obstructive pulmonary
disease (COPD) severity according to medical history of tuberculosis (TB). &: no
COPD; &: stage 0; h: stage I; &: stage II–IV.
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independent from smoking, which is in accordance with
previous studies. HNIZDO et al. [5] expanded this finding by
showing that lung damage is directly associated with the
number of episodes of TB among patients suffering from
silicosis. Possible mechanisms include bronchial stenosis and
lung scarring, and, in addition, similarly to exposure to smoke,
TB increases the activity of the matrix metalloproteinases
enzymes, thus contributing to pulmonary damage [22].
Tobacco smoking and biomass smoke inhalation, in addition
to increasing the risk of TB, may compound the airflow
obstruction caused by TB [23–26]. In fact, a review recently
suggested that subjects smoking o20 cigarettes?day-1 are two to
four times more likely to present with TB than nonsmokers [27].
The present findings are relevant for public health. The
projections from the global burden of disease ranked COPD
as sixth in terms of mortality in low- and middle-income
countries in 2001. TB appeared in eighth position immediately
after HIV infection, which is strongly associated with TB and
was ranked fourth. The reduction of TB is part of the sixth
Millennium Development Goals [28]. The current findings
suggest that by controlling TB, the prevalence of airflow
obstruction may also be reduced.
Some limitations of the study should be considered. First,
medical diagnosis of TB may not reflect the actual incidence of
the disease, because it may be affected by access to diagnostic
and therapeutic facilities. The present analyses were repeated
after excluding all subjects with less than primary education,
and results were unchanged; the overall unadjusted OR, which
was 2.75 in the whole sample, was 2.61 among those with at
least secondary education. Adjustment for schooling did not
substantially affect the association between TB and airflow
obstruction. Recall bias may also affect the results; subjects
who suffer from chronic respiratory conditions may be more
likely to recall previous TB episodes than those who did not
have any sequelae. The current authors believe that subjects
who received treatment for TB are unlikely to under report,
given the long duration and complexity of treatment,
particularly in the past. The analyses was repeated excluding
subjects who were not treated (n521), and the unadjusted OR
was slightly increased (3.14 versus 2.75 in the original analyses).
Another limitation is the fact that the medical diagnosis of TB
was not confirmed by records or image exams due to logistic
and financial limitations. Although this was a cross-sectional
study, reverse causality was unlikely. Peak incidence of TB
occurs in young adults whereas COPD peaks much later, and
the survey was restricted to subjects aged o40 yrs. Prospective
studies are needed on this topic.
Relative to previous studies on this issue, it is important to
highlight that the present study relied on probability samples
of defined urban areas. Nonresponse rates were lower than in
most population-based studies including a physical examin-
ation, such as spirometry [13]. The measurements of lung
function followed strict rules and standardisation [13], and the
fieldwork teams in each country were trained by the same
supervisors, improving comparability in data collection.
The current authors found an important contribution of
tuberculosis to airflow obstruction, linking two of the most
common ailments in the world. The present results suggest
that the prevention and adequate treatment of tuberculosis
would reduce the burden of airflow obstruction in developing
countries.
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